Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

Wyeth: Domestic Centrum sales rose 6% to $93.7 mil. in Q2, making it the only consumer brand of seven broken out by Wyeth to post positive U.S. results in the period. Brand revenue may have been helped by launch of Centrum Performance energy nutrition bars, in stores now (1"The Tan Sheet" May 6, 2002, p. 9). Advil sales fell 11.1% to $93.2 mil. in the U.S., while domestic Caltrate sales were off 10.6% at $15.2 mil. Similar to other cough/cold product manufacturers, Wyeth's financials were negatively impacted by a mild U.S., winter, with both Robitussin (down 9.7%) and Dimetapp (off 8.1%) feeling the effects. Consumer healthcare sales dropped 4% in U.S. to $308.4 mil. and were flat worldwide at $493.1 mil., Wyeth says in 2July 23 earnings release...
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS094341

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel